Epidarex Capital
Finance · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7910 Woodmont Ave Ste 1210, Bethesda, Ma...Phone Number
(301) 298-5455Website
www.epidarex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Epidarex Capital
Epidarex is a transatlantic venture capital firm focused on building breakthrough life science companies in emerging hubs. The firm is led by a diverse team of early-stage investors who act as trusted partners to founders and co-investors. Utilizing their deep scientific and industry networks, Epidarex aims to create exceptional value and shared success. Their portfolio includes innovative biopharmaceutical companies developing precision medicines for various health conditions.Explore more
Epidarex Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epidarex Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Epidarex Capital has new funding data
Product Launch: Get notified when Epidarex Capital launches new products
Website visits: Recent activity has been detected on your website
Check out if Epidarex Capital is spiking on competitors!
Click to see if Epidarex Capital had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Epidarex Capital
Check if Epidarex Capital has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Epidarex Capital recently announced quarterly report
Epidarex Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Epidarex Capital
Compare insights from companies similar to Epidarex Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Epidarex Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Epidarex Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Epidarex Capital.
Epidarex Capital Tech Stack
A closer look at the technologies used by Epidarex Capital
See more technologies
Most Recent Scoops
Award
Award, Spending/Investment, Finance, Operations
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Epidarex Capital News & Media
Epidarex Capital | Globenewswire - Via Ritzau
EPIDAREX CAPITAL ANNOUNCES FIRST CLOSE OF FUND IV, SECURING $145 MILLION TO BUILD NEXT WAVE OF LIFE SCIENCE START-UPSEPIDAREX CAPITAL ANNOUNCES FIRST CLOSE OF FUND IV, SECURING $145 MILLION TO BUILD NEXT WAVE OF LIFE SCIENCE START-UPS
EPIDAREX CAPITAL ANNOUNCES FIRST CLOSE OF FUND IV, SECURING $145 MILLION TO BUILD NEXT WAVE OF LIFE SCIENCE START-UPS£50 million cornerstone commitment to Epidarex Capital | The Pharmaletter
The British Business Bank has made a £50 million ($66.9 million) cornerstone commitment to Epidarex Capital’s next fund. This commitment follows the Bank’s prior cornerstone investment to Epidarex Capital III UK, LP in 2020, where it committed £50 million to a £102 million fund through its Enterprise Capital Funds Program.Theolytics Closes £19M Funding Round
Theolytics, an Oxford, UK-based biotechnology company developing oncolytic viral therapies, raised £19M in funding. Backers included Sound Bioventures, which joined M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises and the University of Oxford. The company intends to use the funds to advance its lead oncolytic adenovirus – THEO-260 – into clinical trials in ovarian […] The post Theolytics Closes £19M Funding Round appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Epidarex Capital
Sign Up For FreeTo access detailed company insights
Epidarex is a transatlantic venture capital firm focused on building breakthrough life science companies in emerging hubs. The firm is led by a diverse team of early-stage investors who act as trusted partners to founders and co-investors. Utilizing their deep scientific and industry networks, Epidarex aims to create exceptional value and shared su... Read More
